Meet The Team

Cesar Herrera leads KRTL Biotech with visionary leadership, focusing on innovation and strategic growth to revolutionize the pharmaceutical and biotech industries. As the founder, he drives the company’s mission to deliver impactful, cutting-edge solutions globally.

Phil Polito defines KRTL Biotech’s long-term strategies, integrating innovation and interdisciplinary thinking to drive sustainable growth. His leadership ensures the company remains adaptive and forward-thinking in a dynamic industry.

Tony Hernandez oversees KRTL Biotech’s operational framework, ensuring seamless execution of strategic initiatives. As a co-founder, his expertise lies in optimizing processes to support the company’s ambitious objectives.

​

Dan Bishop spearheads KRTL Biotech's global expansion, cultivating partnerships and market opportunities worldwide. His role ensures the company’s reach and influence continue to grow across key international regions.

Dr. Stefan Kasian leads KRTL Biotech’s innovative R&D efforts, pioneering experimental methodologies to advance therapeutic solutions. His scientific expertise drives the company’s pipeline of groundbreaking developments.

Dr. Malcolm Leissring provides medical oversight for KRTL Biotech’s initiatives, ensuring the highest standards of safety, efficacy, and compliance in all therapeutic programs. His clinical insights guide the company’s mission to improve patient outcomes.

Dr. Brent LaGrange provides strategic guidance to KRTL Biotech’s research and development efforts, leveraging his expertise to refine and accelerate the innovation pipeline. His role ensures scientific rigor and alignment with the company’s goals for transformative solutions.

Dr. Marcello Bascope advises KRTL Biotech on innovation strategies, identifying emerging opportunities to enhance the company’s competitive edge. His forward-thinking approach fosters the development of groundbreaking advancements in biotechnology.

Kim Skidmore is a seasoned expert in pharmaceutical design, manufacturing, and compliance, with over 17 years of experience. As the founder of an FDA-registered enterprise, she specializes in innovative, holistic health solutions and regulatory excellence. Her expertise in quality systems and FDA standards makes her a valuable advisor to KRTL Biotech, enabling the company delivers high-quality, compliant pharmaceutical and wellness products.

Jill Narciso ensures regulatory compliance and manages critical documentation at KRTL Biotech. Her meticulous approach upholds the company’s operational integrity and alignment with industry standards.

With extensive expertise in the medical device, pharmaceutical, and healthcare industries, Tessa Wheeler is a driving force behind KRTL Biotech’s business development and sales strategies. Her proven ability to build strategic partnerships, create revenue opportunities, and enhance patient care outcomes ensures KRTL remains at the forefront of innovation and growth.